@article{dbb33ffae459490aaff4529bad0ad6ef,
title = "Relapse of BCR-ABL1-like ALL mediated by the ABL1 kinase domain mutation T315I following initial response to dasatinib treatment",
author = "Yeung, \{D. T.\} and Moulton, \{D. J.\} and Heatley, \{S. L.\} and E. Nievergall and P. Dang and J. Braley and S. Branford and S. Moore and Mullighan, \{C. G.\} and Hughes, \{T. P.\} and White, \{D. L.\}",
note = "Funding Information: TPH has received honoraria, participated on the advisory boards of, and received research funding from BMS, Novartis and Ariad. DLW and SB have received honoraria and research funding from BMS, Novartis and Ariad. DTY has received honoraria, participated on the advisory boards of and received research funding from BMS and Novartis. The remaining authors declare no conflict of interest. Funding Information: DTY is supported by a PhD scholarship from the Leukaemia Foundation of Australia and the Royal Adelaide Hospital Research AR Clarkson Foundation. TPH is a NHMRC Practitioner Fellow. This project was funded by a Beat Cancer Grant from the Cancer Council of SA, an Australasian Leukaemia and Lymphoma Group start-up Grant and subsequently by an NHMRC project grant.",
year = "2015",
month = jan,
day = "10",
doi = "10.1038/leu.2014.256",
language = "English",
volume = "29",
pages = "230--232",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Springer Nature",
number = "1",
}